Clinical trial
Dietary Omega-3 Fatty Acids as a Therapeutic Strategy in Insulin Resistant Humans
NCT01686568 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dietary Omega-3 Fatty Acids as a Therapeutic Strategy in Insulin Resistant Humans
- Lead sponsor
- Mayo Clinic
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 21, 2012
- Completion date
- June 8, 2015
- Enrollment
- 31 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.